| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/25/2010 | US20100048565 Benzimidazole derivatives |
| 02/25/2010 | US20100048551 Tricyclic Compounds Useful as Inhibitors of Kinases |
| 02/25/2010 | US20100048549 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 |
| 02/25/2010 | US20100048521 Combination of a gluco-korticoid and beta-cyclodextrin conjugated vitamin a-derivate complex |
| 02/25/2010 | US20100048514 Use of phospholipids for wound healing |
| 02/25/2010 | US20100048488 Immunomodulatory peptides |
| 02/25/2010 | US20100048484 Methods for treating diabetic wounds |
| 02/25/2010 | US20100047362 Method and Pharmaceutical Composition for Improvement of Wound Healing |
| 02/25/2010 | US20100047361 Active Principle which is capable of inducing the conversion of inactive TGFb-Latent into active TGFb |
| 02/25/2010 | US20100047360 Use Of Polyamines In The Treatment Of Psoriasis |
| 02/25/2010 | US20100047357 Compositions for topical application comprising a peroxide and retinoid |
| 02/25/2010 | US20100047356 Charge-assembled capsules for phototherapy |
| 02/25/2010 | US20100047332 Treatments for burns using thyroid hormone compound in a human |
| 02/25/2010 | US20100047328 Adhesive preparation |
| 02/25/2010 | US20100047325 Analgesic anti-inflammatory patches for topical use |
| 02/25/2010 | US20100047324 Multi-Functional Wound Dressing Matrices and Related Methods |
| 02/25/2010 | US20100047308 Production methods of virus inactivated and cell-free body implant |
| 02/25/2010 | US20100047305 Extracellular Matrix Compositions |
| 02/25/2010 | US20100047259 Follistatin domain containing proteins |
| 02/25/2010 | US20100047236 Antibody variants |
| 02/25/2010 | US20100047196 Novel microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics |
| 02/25/2010 | US20100047195 Lip balm and method of treating lip conditions |
| 02/25/2010 | DE102008039231A1 Verwendung von Glucosylglycerol Use of Glucosylglycerol |
| 02/25/2010 | DE102008039126A1 Dermatological ointment, useful for treating e.g. allergy and eczema, comprises fatty acids in the form of stearic acids and oleic acids of shea butter, glucose and fructose, fatty acids of chia oil and hemp oil |
| 02/25/2010 | DE102008037337A1 Verfahren zur Herstellung von Wirkstoffen, insbesondere Phenolen aus einer Pflanze A process for the preparation of active compounds, in particular phenols from a plant |
| 02/25/2010 | CA2735048A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazolo[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 02/25/2010 | CA2734896A1 Therapeutic substituted pyrroles |
| 02/25/2010 | CA2734358A1 Treatment of an autoimmune disease using il-18 antagonists |
| 02/25/2010 | CA2733514A1 Formulation for oral administration of proteins |
| 02/24/2010 | EP2157097A1 Specific binding agents of human angiopoietin-2 |
| 02/24/2010 | EP2157081A1 Indolinones substituted in six locations, their manufacture and their application as medicine |
| 02/24/2010 | EP2156843A2 Use of low-dose erythropoietin for the treatment of acute or chronic renal insufficiency and for the treatment of wounds |
| 02/24/2010 | EP2156842A1 Oral composition |
| 02/24/2010 | EP2156837A1 Crystalline micropowder particles |
| 02/24/2010 | EP2156820A1 Skin whitening agent |
| 02/24/2010 | EP2155662A2 Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |
| 02/24/2010 | EP2155235A1 Oxygen-generating compositions for enhancing cell and tissue survival in vivo |
| 02/24/2010 | EP2155206A1 Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide |
| 02/24/2010 | EP2155184A2 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies |
| 02/24/2010 | EP2155146A1 Methods and compositions for treating skin conditions |
| 02/24/2010 | EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 02/24/2010 | EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 02/24/2010 | EP1185621B1 Surface for cell culture |
| 02/24/2010 | EP1112087B1 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN101653604A Anti-ngf antibodies for the treatment of various disorders |
| 02/24/2010 | CN101653603A Peptides and antibodies binding to anionic phospholipids and aminophospholipids and their use in treating disease |
| 02/24/2010 | CN100591329C Montelukast granule formulation |
| 02/24/2010 | CN100591328C Cosmetic compositions containing chick pea extract and retinoids |
| 02/24/2010 | CN100591320C Stable surfactant compositions for suspending components |
| 02/23/2010 | USRE41151 Comprising a modified NSAID, wherein the NSAID is covalently attached either directly or through a linker molecule to a sulfur-containing functional group containing an optionally substituted hydrocarbyl moiety; nonsteroidal anti-inflammatory drugs; side-effect reduction |
| 02/23/2010 | US7667040 Azacyclic ethynyl derivatives |
| 02/23/2010 | US7667021 Neutralizing human anti-IGFR antibody |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7667007 αvβ3-specific antibodies |
| 02/23/2010 | US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
| 02/23/2010 | US7666885 Enzyme inhibitors |
| 02/23/2010 | US7666873 N-phenyl-(2R,5S)dimethylpiperazine derivative |
| 02/23/2010 | US7666859 Skin compositions containing hydrocortisone |
| 02/23/2010 | US7666848 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 02/23/2010 | US7666847 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| 02/23/2010 | US7666839 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 02/23/2010 | US7666832 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666831 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666675 Hair follicle stem cells for use in the treatment of nervous system disorders and cell therapy |
| 02/23/2010 | US7666443 Dispersed particle compositions for enhancing post wash hydration comprising amphiphiles and moisturization additives of defined HLB |
| 02/23/2010 | US7666440 Dermatomycosis vaccine |
| 02/23/2010 | US7666422 Methods for the treatment of cancer using anti-CD40 antibodies |
| 02/23/2010 | US7666418 Method for treating Th2-mediated disease |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |
| 02/23/2010 | CA2541814C Pharmaceutical compositions comprising malonamide derivatives for decreasing sebum production |
| 02/23/2010 | CA2470492C Aqueous compositions containing metronidazole |
| 02/23/2010 | CA2448596C Topical treatments using alkanolamines |
| 02/23/2010 | CA2433021C Isoindole-imide compounds, compositions, and uses thereof |
| 02/23/2010 | CA2319916C Use of dhea, its precursors or its metabolic derivatives as a depigmentation agent |
| 02/18/2010 | WO2010019864A2 Ficus extracts having angiogenesis inhibiting activity and methods of isolating and using the same |
| 02/18/2010 | WO2010019536A1 Therapeutic compounds |
| 02/18/2010 | WO2010019450A2 Synergizing active compounds for treating inflammation and other conditions |
| 02/18/2010 | WO2010019413A2 Composite particles having an antioxidant-based protective system, and topical compositions comprising the same |
| 02/18/2010 | WO2010019059A1 Veterinary preparation |
| 02/18/2010 | WO2010018837A2 Protein cross-linking inhibitor |
| 02/18/2010 | WO2010018836A2 Polyglutamine aggregation inhibitor |
| 02/18/2010 | WO2010018614A1 Hydrophilic amino acid-containing preparation having improved taste |
| 02/18/2010 | WO2010017895A1 Use of indole compounds as a cosmetic |
| 02/18/2010 | WO2010017598A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | WO2009153373A3 Dermatological pharmaceutical composition for the treatment of skin inflammation diseases, such as dermatitis, atopic dermatitis, vitiligo, alopecia areata, acne, psoriasis, pruritus or combinations of same |
| 02/18/2010 | WO2009126302A3 Stabilized oleosome preparations and methods of making them |
| 02/18/2010 | WO2009126301A3 Controlled release of active agents from oleosomes |
| 02/18/2010 | WO2009083203A3 Topical application and formulation of erythropoietin for skin wound healing |
| 02/18/2010 | WO2009076602A8 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 02/18/2010 | US20100041757 N-aryl-hydroxyalkylidene-carboxamide compounds and their use |
| 02/18/2010 | US20100041634 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy |
| 02/18/2010 | US20100041627 Compositions comprising polymeric emulsifiers and methods of using same |
| 02/18/2010 | US20100041616 Formulations for Nonsurgical Exogenous Crosslink Therapy |
| 02/18/2010 | US20100041608 Method for stimulating wound healing |
| 02/18/2010 | US20100041605 Use of VEGF-C or VEGF-D in Reconstructive Surgery |
| 02/18/2010 | US20100041603 Method of Promoting Wound Healing |
| 02/18/2010 | US20100041590 Compounds |
| 02/18/2010 | US20100041136 Connective Tissue Growth Factor-2 |
| 02/18/2010 | US20100040710 Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers. |